Mawi DNA is working with Biotessia to start a local production site for DNA sample collection technologies and kits. These will be provided to African markets at a significantly lower cost.
Mawi DNA Technologies (Mawi), a leading biosample collection company, is engaging in a joint venture with Moroccan medical device company BIOTESSIA to serve the African market.
The goal of Mawi DNA and Biotessia’s joint venture is to produce DNA/RNA, Forensics, Microbiome and blood room temperature stable bio-sample collection technologies and kits in Morocco, targeting African and European countries. Aiming to provide high quality DNA sampling at more affordable prices.
The two companies secured a grant from Morocco’s government for 25% of the capital required to start the project The funding will support Biotessia’s vision to distribute diagnostic tests that help detect common diseases in Morocco and Africa, especially in the rural and secluded areas of the continent.
Mawi DNA Technologies Partners with GenoBank.io To Tokenize Our Groundbreaking…...
October 14, 2024 – We are thrilled to announce that Mawi DNA Technologies has officially partnered with READ MORE
Mawi DNA Partners with Tempus AI and Tally Health™ to…...
October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, incl...
READ MORESolena Ag and Mawi DNA Partner to Revolutionize Soil Health…...
January 4, 2024 – Solena Ag, a leader in soil health insights for sustainable agriculture, and Mawi DNA Technologies (Mawi DNA), a pioneer in high-integrity sample collection and storage, today anno...
READ MORE
